Skip to main content
Close Search
Helixafe
Menu
  • Cancer Driver Interception
    • Interception vs Prevention
    • Cancer Prevention Models
    • Cancer Driver Condition
    • Genomic Instability
      • How is Linked to Cancer
      • Somatic Mutation and Cancer Prodromal Stage
      • Assessing genomic Instability
      • Analyzing cfDNA to Assess Genomic Instability
    • White Paper
  • Tumor Environment
    • Inflammation
      • The Causes of Inflammation
      • The Role of Inflammation in Cancer
      • The Actionable Biomarkers of Inflammation
      • Lifestyle Against Inflammation
    • Immune System
      • Aging and the Immune System
      • T Cells
      • B Cells
      • Monocytes
      • NK Cells
      • Vitamin D and the Immune System
    • Microbiome
      • Dysbiosis
      • Microbiota and Cancer Development
      • Microbiota and the Immune System
      • Microbiota and Inflammation
      • Microbiota and Genomic Instability
      • Microbiota and Obesity
      • Microbiota and Aging
      • Microbiota and Modifying Factors
      • How to Analyse Gut Microbiota
    • Telomere
      • Telomere Structure and Functions
      • Telomeres in Cancer
      • Telomere Shortening and Cancer
      • Telomere Shortening and Genomic Instability
      • Longer Telomeres and Cancer
  • Education
    • Cancer Prevention
    • Education for Physicians
    • Education for the General Public
    • Education for Former Cancer Patients
    • Sustainable Development Goals
    • Molecular Pathology in Cancer Prevention
  • Contact us
    La Prevenzione personalizzata dei tumori: “INTERCETTARE” i fattori di rischio latest-news

    La Prevenzione personalizzata dei tumori: “INTERCETTARE” i fattori di rischio

    In collaborazione con: Dipartimento di Oncologia ed Emato-oncologia dell’ Università degli Studi di Milano Mercoledì,…
    Giampaolo Venturi
    Giampaolo VenturiApril 12, 2024
    20 miliardi di euro l’anno: i costi per il cancro in Italia – Prevenzione attiva, la vera arma vincente latest-news

    20 miliardi di euro l’anno: i costi per il cancro in Italia – Prevenzione attiva, la vera arma vincente

    CNEL, Plenaria Marco Biagi, Viale Davide Lubin 2, Roma Venerdì 15 dicembre 2023, ore 11.00…
    admin
    adminDecember 15, 2023
    Nuovo approccio nella prevenzione dei tumori. In Italia il primo modello al mondo latest-news

    Nuovo approccio nella prevenzione dei tumori. In Italia il primo modello al mondo

    Su iniziativa del Sen. Francesco Zaffini Presidente della Commissione 10a  Affari sociali, sanità, lavoro pubblico…
    admin
    adminOctober 11, 2023

    Recent Posts

    • La Prevenzione personalizzata dei tumori: “INTERCETTARE” i fattori di rischio
    • 20 miliardi di euro l’anno: i costi per il cancro in Italia – Prevenzione attiva, la vera arma vincente
    • Nuovo approccio nella prevenzione dei tumori. In Italia il primo modello al mondo

    Archives

    • April 2024
    • December 2023
    • October 2023

    Categories

    • latest-news

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    About the blog

    Lorem ipsum dolor sit amet, consectetur elit porta. Vestibulum ante justo, volutpat quis porta non, vulputate id diam. Lorem et ipsum dolor sit amet, consectetur adipiscing elit. Morbi vitae sem in massa sagittis.

    Recent Posts

    • La Prevenzione personalizzata dei tumori: “INTERCETTARE” i fattori di rischio April 12, 2024
    • 20 miliardi di euro l’anno: i costi per il cancro in Italia – Prevenzione attiva, la vera arma vincente December 15, 2023
    • Nuovo approccio nella prevenzione dei tumori. In Italia il primo modello al mondo October 11, 2023
    Bioscience Institute

    BIOSCIENCE is the first and only company in the world to introduce the cancer driver interception model as a valuable alternative to Cancer Early Detection in colorectal cancer prevention.

    Headquarters

    BIOSCIENCE INSTITUTE
      Strada Rovereta, 42 - 47891 Falciano
    Repubblica di San Marino
    Tel. 0549 909905 - Fax 0549 941580
    E-mail: info@bioinst.com
    Web: www.bioinst.com

    Copyrights © 2005-2025 All Rights Reserved Bioscience Institute SpA | Privacy Policy | Cookie Policy

    • twitter
    • facebook
    • linkedin
    • instagram
    Close Menu
    • Cancer Driver Interception
      • Interception vs Prevention
      • Cancer Prevention Models
      • Cancer Driver Condition
      • Genomic Instability
        • How is Linked to Cancer
        • Somatic Mutation and Cancer Prodromal Stage
        • Assessing genomic Instability
        • Analyzing cfDNA to Assess Genomic Instability
      • White Paper
    • Tumor Environment
      • Inflammation
        • The Causes of Inflammation
        • The Role of Inflammation in Cancer
        • The Actionable Biomarkers of Inflammation
        • Lifestyle Against Inflammation
      • Immune System
        • Aging and the Immune System
        • T Cells
        • B Cells
        • Monocytes
        • NK Cells
        • Vitamin D and the Immune System
      • Microbiome
        • Dysbiosis
        • Microbiota and Cancer Development
        • Microbiota and the Immune System
        • Microbiota and Inflammation
        • Microbiota and Genomic Instability
        • Microbiota and Obesity
        • Microbiota and Aging
        • Microbiota and Modifying Factors
        • How to Analyse Gut Microbiota
      • Telomere
        • Telomere Structure and Functions
        • Telomeres in Cancer
        • Telomere Shortening and Cancer
        • Telomere Shortening and Genomic Instability
        • Longer Telomeres and Cancer
    • Education
      • Cancer Prevention
      • Education for Physicians
      • Education for the General Public
      • Education for Former Cancer Patients
      • Sustainable Development Goals
      • Molecular Pathology in Cancer Prevention
    • Contact us